Newtyn Partners, L.P., Director Other at MERRIMACK PHARMACEUTICALS INC (MACK), bought 138,174 shares at $3.65 ($504K) on 2020-11-24, disclosed to the SEC on 2020-11-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.65 | 28,809 | $105K | 20.8% |
| 2 | $3.65 | 28,809 | $105K | 20.8% |
| 3 | $3.65 | 40,278 | $147K | 29.2% |
| 4 | $3.65 | 40,278 | $147K | 29.2% |
| Total | $3.65 avg | 138,174 | $504K | 100% |
| Filing → |
| MACK | BUY | 2022-06-16 | $186K | — | Filing → |
| MACK | BUY | 2022-02-01 | $116K | — | Filing → |